arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Organogenesis Holdings Inc.

ORGO

$1.85 ▼ -0.15 (-7.50%) at close

11 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

Organogenesis Holdings Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $234.5M

Dividend Yield —

Revenue Growth 17.0% ↗

Op. Margin 7.9% ↗

ROIC 11.7% ↗

FCF / Share $-0.19 ↘

Trailing P/E 11.6x

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$564.17M

↑ +17.0% —

Net Income Profit after all expenses

$37.03M

↑ +4201.0% —

Operating Margin Operating profit as % of sales

7.9%

↑ +3076.5% 51th

FCF / Share Free cash flow per share

$-0.19

↓ -708.5% —

Long-Term Debt Long-term obligations

$71.25M

↓ -3.8% —

Health Breakdown

Profitability ↓

Returns ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	17.0% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+113%)	11.3% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+41%)	-3.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-149%)	-3.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-146%)	38.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+379%)	29.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+270%)	34.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+336%)	-2.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-132%)	43.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+439%)	—	—
EPS Growth YoY (%)	N/M	N/M	-66.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-83.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	362.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—
Net Income Growth YoY (%)	4201.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-82.6% Weak ↓ Weak Declining Year-over-year change in net income	-68.2% Weak ↓ Weak Declining Year-over-year change in net income	-83.6% Weak ↓ Weak Declining Year-over-year change in net income	450.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	37.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-672.9% Weak Weak Year-over-year change in net income	50.6% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	-36.5% Weak Weak Year-over-year change in free cash flow	N/M	N/M	N/M	73.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	7.8% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	1.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	8.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	20.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	34.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	19.4% Excellent Excellent Compound annual revenue growth over 3 years	23.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	10.8% Good ↓ Good Declining Compound annual revenue growth over 5 years	13.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	17.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	17.8% Excellent Excellent Compound annual revenue growth over 5 years	27.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	10.1% Good Good Compound annual EPS growth over 3 years	—	-37.0% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	7.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-47%)	-0.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-102%)	2.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-81%)	4.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	15.6% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	7.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-47%)	-11.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-175%)	-26.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-278%)	-2.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-118%)	-6.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-142%)	—
Effective Tax Rate (%) (%)	21.2% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	130.7% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	52.4% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	23.4% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-48.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	48.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	6.6% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-45%)	0.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-99%)	1.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-90%)	3.4% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-71%)	20.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+69%)	5.1% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-58%)	-15.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-229%)	-33.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-379%)	-4.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-135%)	-12.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-202%)	—
FCF Margin (%) (%)	-4.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	0.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	1.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-2.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-15.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-32.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-3.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-4.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	4.85x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.71x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	11.7% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	0.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.1% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	34.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	18.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-109.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	55.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	7.5% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-0.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.0% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	16.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	9.2% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-3.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	12.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-98%)	1.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-88%)	5.8% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	39.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+161%)	12.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-19%)	-72.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-585%)	-137.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1019%)	54.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+265%)	106.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+609%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Debt to Equity (x)	—	—	—	0.27x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-55%)	0.31x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-49%)	—	—	—	-3.40x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-667%)	—	—
Interest Coverage (x)	—	-0.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	2.30x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	11.10x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	10.08x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	2.37x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-3.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.78x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.68x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1.56x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-93.68M	$-135.57M	$-103.84M	$-31.23M	$-39.87M	$-84.39M	—	—	$52.14M	—	—
Debt / EBITDA (x)	—	—	—	2.53x Fair Fair Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.94x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-27.40x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$4.45	$3.66	$3.30	$3.47	$3.65	$3.14	$2.81	—	—	—	—
Basic EPS, GAAP (USD)	$0.16	$-0.01	$0.04	$0.12	$0.74	$0.16	$-0.44	—	—	—	—
Free Cash Flow per Share (USD)	$-0.19	$0.03	$0.05	$-0.07	$0.24	$-0.11	$-0.43	—	—	—	—
Book Value per Share (USD)	$2.36	$2.09	$2.12	$2.03	$1.88	$1.11	$0.53	$0.52	$-0.23	—	—
Tangible Book Value per Share (USD)	$2.07	$1.76	$1.78	$1.65	$1.46	$0.65	$0.09	$-0.05	$-1.05	—	—
Basic Weighted Avg Shares (shares)	126.74M	131.67M	131.23M	130.07M	128.33M	107.74M	92.84M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$262.06M	$208.46M	$144.53M	$147.59M	$144.97M	$106.13M	$65.71M	$15.04M	$-2.23M	—	$-290.37K
LT Debt (USD)	—	—	—	$71.25M	$74.06M	—	—	—	$52.14M	—	—
Total Equity (USD)	$300.13M	$262.90M	$278.66M	$265.67M	$242.03M	$141.81M	$55.58M	$47.04M	$-15.32M	$-15.98M	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$564.17M	$482.04M	$433.14M	$450.89M	$468.06M	$338.30M	$260.98M	$193.45M	$198.51M	$138.73M	—
Depreciation Expense (USD)	$15.27M	$13.62M	$10.45M	$5.84M	$5.78M	$4.44M	$3.39M	$3.31M	$3.59M	$5.70M	—
Net Income, GAAP (USD)	$37.03M	$861.00K	$4.95M	$15.53M	$94.90M	$17.23M	$-40.45M	$-64.83M	$-8.39M	$-16.99M	—
Operating Cash Flow (USD)	$-10.31M	$14.21M	$30.92M	$24.86M	$61.98M	$5.47M	$-33.53M	$-60.63M	$-3.57M	$-4.87M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 42 quarters

Organogenesis Holdings Inc.

Analytical Summary

11-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ORGO with peers